![Vidar Wendel-Hansen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vidar Wendel-Hansen
Directeur Technique/Scientifique/R&D chez
QUIAPEG PHARMACEUTICALS HOLDING AB
Profil
Dr. Vidar Wendel-Hansen is a Chief Medical Officer at Toleranzia AB and a Chief Medical Officer at QUIA PHARMA AB. He is on the Board of Directors at Castello Di Vaglio Serra AB and VWH & Co. AB. Dr. Wendel-Hansen was previously employed as a Chief Executive Officer by Axelar AB, a Chief Medical Officer & EVP-Development by Bionor Pharma ASA, a Senior Vice President-Clinical Development by Resistentia Pharmaceuticals AB, a Co-Founder by Arexis AB, a Medical Director-Nordic & Baltic Region by Gilead Sciences, Inc., and a Co-Founder by Quiatech AB. He also served on the board at Asarina Pharma AB and Novartis Sverige AB. He received his doctorate degree from Karolinska Institutet.
Postes actifs de Vidar Wendel-Hansen
| Sociétés | Poste | Début |
|---|---|---|
| QUIAPEG PHARMACEUTICALS HOLDING AB | Directeur Technique/Scientifique/R&D | - |
VWH & Co. AB | Directeur/Membre du Conseil | - |
Castello Di Vaglio Serra AB | Directeur/Membre du Conseil | - |
Anciens postes connus de Vidar Wendel-Hansen
| Sociétés | Poste | Fin |
|---|---|---|
| ASARINA PHARMA AB | Directeur/Membre du Conseil | 05/05/2020 |
Resistentia Pharmaceuticals AB
 Resistentia Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops immunotherapy products | Corporate Officer/Principal | 24/06/2010 |
Axelar AB
 Axelar AB BiotechnologyHealth Technology Provides oral anti-cancer therapies | Directeur Général | - |
Novartis Sverige AB
 Novartis Sverige AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical, ophthalmic and generic drugs | Directeur/Membre du Conseil | - |
| TOLERANZIA AB | Directeur Technique/Scientifique/R&D | - |
Formation de Vidar Wendel-Hansen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
37
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Resistentia Pharmaceuticals AB
Resistentia Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops immunotherapy products | Health Technology |
Arexis AB
 Arexis AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Quiatech AB
 Quiatech AB Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Axelar AB
Axelar AB BiotechnologyHealth Technology Provides oral anti-cancer therapies | Health Technology |
Novartis Sverige AB
Novartis Sverige AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical, ophthalmic and generic drugs | Health Technology |
Asarina Pharma AB
 Asarina Pharma AB Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Bionor Pharma ASA
 Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Manufactures nutritional supplements and vaccines | Health Technology |
Toleranzia AB
 Toleranzia AB BiotechnologyHealth Technology Operates as a biotechnology company that develops drugs for the treatment of autoimmune orphan diseases | Health Technology |
Quiapeg Pharmaceuticals Holding AB
 Quiapeg Pharmaceuticals Holding AB BiotechnologyHealth Technology Provides holdings in developing biopharmaceuticals for the treatment of metabolic disorders | Health Technology |
VWH & Co. AB | |
Castello Di Vaglio Serra AB |
